<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02665273</url>
  </required_header>
  <id_info>
    <org_study_id>2015-4754</org_study_id>
    <nct_id>NCT02665273</nct_id>
  </id_info>
  <brief_title>Greater Occipital Nerve Block With Bupivacaine for Acute Migraine</brief_title>
  <official_title>A Randomized, Sham-controlled Trial of Greater Occipital Nerve Block as Second Line Therapy for ED Patients With Acute Migraine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montefiore Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Montefiore Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized, sham-controlled study of greater occipital nerve block (GONB) using
      bupivacaine 0.5% for emergency department patients with acute migraine. Patients are only
      enrolled if they fail first line therapy with metoclopramide.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators are testing the following hypothesis:

      In a population of patients who present to an ED with acute migraine and have been treated
      with parenteral metoclopramide unsuccessfully, bilateral greater occipital nerve blocks with
      bupivicaine will provide greater rates of short-term and sustained headache freedom than
      bupivacaine injected intradermally.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2015</start_date>
  <completion_date type="Anticipated">May 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Headache freedom</measure>
    <time_frame>30 minutes</time_frame>
    <description>Pain assessed using the following scale: &quot;severe,&quot; &quot;moderate,&quot; &quot;mild,&quot; or &quot;none&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sustained headache relief</measure>
    <time_frame>48 hours</time_frame>
    <description>Attaining a headache level of &quot;mild&quot; or &quot;none&quot; within one hour of procedure and maintaining this for 48 hours without use of additional medication</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Satisfaction</measure>
    <time_frame>48 hours</time_frame>
    <description>Participants will be asked the following question: Do you want to receive the same procedure the next time you come to the ER with migraine?</description>
  </secondary_outcome>
  <other_outcome>
    <measure>0-10 verbal pain score</measure>
    <time_frame>48 hours</time_frame>
    <description>0-10 pain scores will be obtained in the ED and after ED discharge</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Migraine</condition>
  <arm_group>
    <arm_group_label>Greater occipital nerve block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bilateral greater occipital nerve block with 3cc of 0.5% bupivacaine, delivered using fan technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Bilateral intradermal injection of 0.5cc of 0.5% bupivacaine, delivered superficially to the area overlying the greater occipital nerve</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Greater occipital nerve block</intervention_name>
    <description>Bilateral greater occipital nerve block</description>
    <arm_group_label>Greater occipital nerve block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sham</intervention_name>
    <description>0.5 cc of 0.5% bupivacaine injected intradermally</description>
    <arm_group_label>Sham</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ED patient with acute migraine or probable migraine

          -  Fail first line therapy with metoclopramide

        Exclusion Criteria:

          -  Can't obtain consent

          -  Concern for secondary headache

          -  Skull defect

          -  Propensity for bleeding

          -  Overlying infection

          -  Pregnancy

          -  Allergy, intolerance study medication
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benjamin W Friedman, MD, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Albert Einstein College of Medicine, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Belinda Tavarez</last_name>
    <phone>718-920-6626</phone>
    <email>btavarez@montefiore.org</email>
  </overall_contact>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Belinda Tavarez</last_name>
      <phone>718-920-6626</phone>
      <email>btavarez@montefiore.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 15, 2016</study_first_submitted>
  <study_first_submitted_qc>January 22, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 27, 2016</study_first_posted>
  <last_update_submitted>December 10, 2017</last_update_submitted>
  <last_update_submitted_qc>December 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 12, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Montefiore Medical Center</investigator_affiliation>
    <investigator_full_name>Benjamin Friedman</investigator_full_name>
    <investigator_title>PI</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

